Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Centofanti

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Expert Review of Molecular Diagnostics|August 1, 2012
Molecular diagnostics of ocular diseases: the application of antibody microarrayAlberto Izzotti, Marco Centofanti, Sergio Claudio Saccà
Investigative Ophthalmology & Visual Science|May 24, 2012
New proteins as vascular biomarkers in primary open angle glaucomatous aqueous humorSergio Claudio Saccà, Marco Centofanti, Alberto Izzotti
Progress in Brain Research|October 22, 2008
Intraocular pressure and central corneal thicknessGianluca Manni, Francesco Oddone, Vincenzo Parisi, et al.
Investigative Ophthalmology & Visual Science|September 28, 2007
The effects of intraocular pressure reduction on perimetric variability in glaucomatous eyesPaolo Fogagnolo, Andrew McNaught, Marco Centofanti, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|June 7, 2003
Age- and gender-related differences in human lacrimal fluid peroxidase activityGiordana Marcozzi, Veronica Liberati, Federica Madia, et al.
Journal of Cellular Physiology|February 7, 2014
Nerve growth factor modulation of retinal ganglion cell physiologyGloria Roberti, Flavio Mantelli, Ilaria Macchi, et al.
Ophthalmology|January 13, 2006
Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucomaVincenzo Parisi, Stefano Miglior, Gianluca Manni, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 9, 2004
A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patientsGianluca Manni, Marco Centofanti, Mariacristina Parravano, et al.
American Journal of Ophthalmology|January 18, 2005
Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockersGianluca Manni, Marco Centofanti, Francesco Oddone, et al.
American Journal of Ophthalmology|December 13, 2006
Prevention of dermatologic side effects of bimatoprost 0.03% topical therapyMarco Centofanti, Francesco Oddone, Sergio Chimenti, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Expert Review of Molecular Diagnostics|August 1, 2012
Molecular diagnostics of ocular diseases: the application of antibody microarrayAlberto Izzotti, Marco Centofanti, Sergio Claudio Saccà
Investigative Ophthalmology & Visual Science|May 24, 2012
New proteins as vascular biomarkers in primary open angle glaucomatous aqueous humorSergio Claudio Saccà, Marco Centofanti, Alberto Izzotti
Progress in Brain Research|October 22, 2008
Intraocular pressure and central corneal thicknessGianluca Manni, Francesco Oddone, Vincenzo Parisi, et al.
Investigative Ophthalmology & Visual Science|September 28, 2007
The effects of intraocular pressure reduction on perimetric variability in glaucomatous eyesPaolo Fogagnolo, Andrew McNaught, Marco Centofanti, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|June 7, 2003
Age- and gender-related differences in human lacrimal fluid peroxidase activityGiordana Marcozzi, Veronica Liberati, Federica Madia, et al.
Journal of Cellular Physiology|February 7, 2014
Nerve growth factor modulation of retinal ganglion cell physiologyGloria Roberti, Flavio Mantelli, Ilaria Macchi, et al.
Ophthalmology|January 13, 2006
Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucomaVincenzo Parisi, Stefano Miglior, Gianluca Manni, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 9, 2004
A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patientsGianluca Manni, Marco Centofanti, Mariacristina Parravano, et al.
American Journal of Ophthalmology|January 18, 2005
Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockersGianluca Manni, Marco Centofanti, Francesco Oddone, et al.
American Journal of Ophthalmology|December 13, 2006
Prevention of dermatologic side effects of bimatoprost 0.03% topical therapyMarco Centofanti, Francesco Oddone, Sergio Chimenti, et al.
Pageof 5